What is Main Line Acupuncture?
Founded in 2009 by Dr. Dongxiao Liu, Main Line Acupuncture & Oriental Medicine has established itself as a premier provider of Traditional Chinese Medicine. The practice distinguishes itself through a comprehensive suite of services, including acupuncture, acupressure, cupping, and customized herbal therapy. With a clinical focus on complex health challenges such as chronic pain management, infertility, and women's health, the company bridges the gap between ancient healing modalities and modern patient expectations. Operating across key locations in Ardmore and Wilmington, the firm maintains a high standard of personalized care, supported by a deep commitment to evidence-based holistic outcomes.
How much funding has Main Line Acupuncture raised?
Main Line Acupuncture has raised a total of $14K across 1 funding round:
Debt
$14K
Debt (2021): $14K with participation from PPP
Key Investors in Main Line Acupuncture
PPP
Public-Private Partnership
What's next for Main Line Acupuncture?
With the recent influx of capital, Main Line Acupuncture is well-positioned to scale its operational infrastructure and enhance its service delivery model. The current Series A/B growth stage suggests a pivot toward expanding clinical capacity and potentially integrating advanced digital health tools to streamline patient management. As the company continues to navigate the evolving wellness sector, the focus will likely remain on deepening its regional footprint while maintaining the high-touch, personalized care that has defined its reputation over the past decade. Future strategic initiatives may include the recruitment of additional specialized practitioners and the expansion of insurance network partnerships to drive long-term sustainability.
See full Main Line Acupuncture company page